Onvansertib, a polo-like kinase 1 inhibitor, inhibits prostate stromal cell growth and prostate smooth muscle contraction, which is additive to inhibition by α1-blockers
Xiaolong Wang, Bingsheng Li, Anna Ciotkowska, Beata Rutz, Mark G. Erlander, Maya Ridinger, Ruixiao Wang, Alexander Tamalunas, Raphaela Waidelich, Christian G. Stief, Martin Hennenberg
Topics & Concepts
ProstateTamsulosinContraction (grammar)EndocrinologyInternal medicineViability assayMedicineStromal cellLower urinary tract symptomsEndothelin 1HyperplasiaChemistryApoptosisReceptorBiochemistryCancerUrinary Bladder and Prostate ResearchProstate Cancer Diagnosis and TreatmentUrologic and reproductive health conditions